TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16496034

Group type: EXPERIMENTAL
Intervention: Naltrexone treatment
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Naltrexone treatment (adherent)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Methadone maintenance (control)
Number of subjects: 80
Study: 14625708

Group type: EXPERIMENTAL
Intervention: Isoflurane (ISO group; n = 20)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sevoflurane (SEV group; n = 20)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Isoflurane and Sevoflurane (both groups)
Number of subjects: 40
Study: 11122842

Group type: EXPERIMENTAL
Intervention: Allogeneic transplantation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonmyeloablative preparative regimens
Number of subjects: 0
Study: 9494591

Group type: COMPARATOR
Intervention: Goserelin alone
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Goserelin plus mitomycin C
Number of subjects: 67

Group type: COMPARATOR
Intervention: Both groups (Goserelin alone and Goserelin plus mitomycin C)
Number of subjects: 67
Study: 8182270

Group type: EXPERIMENTAL
Intervention: 25 units iHAV i.m. at 0 and 24 weeks
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Booster dose of 25 units iHAV i.m. given 1 or 2 months after primary immunization
Number of subjects: 75

Group type: COMPARATOR
Intervention: 0.06 ml/kg IG i.m. given once
Number of subjects: 75
Study: 3001523

Group type: EXPERIMENTAL
Intervention: Acyclovir
Number of subjects: 22

Group type: COMPARATOR
Intervention: Vidarabine
Number of subjects: 22
Study: 29624887

Group type: EXPERIMENTAL
Intervention: DS-8500a 75 mg
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 29703262

Group type: EXPERIMENTAL
Intervention: Migalastat 150 mg every other day
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 27107523

Group type: EXPERIMENTAL
Intervention: 20 ml of hyperbaric bupivacaine 0.25% plus 1mL of sufentanil
Number of subjects: 50

Group type: COMPARATOR
Intervention: 20 ml of hyperbaric bupivacaine 0.25% plus 1mL of placebo
Number of subjects: 50
Study: 22078217

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT) group treatment
Number of subjects: 21

Group type: COMPARATOR
Intervention: Waitlist condition
Number of subjects: 21
Study: 20729016

Group type: EXPERIMENTAL
Intervention: Orange juice (500 mL/d) with aerobic training (1h, 3 times a week for 3 months)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Aerobic training (1h, 3 times a week for 3 months) without orange juice
Number of subjects: 26
Study: 17078440

Group type: EXPERIMENTAL
Intervention: Acupuncture and cupping
Number of subjects: 80

Group type: COMPARATOR
Intervention: Ritaline
Number of subjects: 80
Study: 15333465

Group type: EXPERIMENTAL
Intervention: Homozygous individuals carrying the Glu variant of APE1
Number of subjects: 463

Group type: EXPERIMENTAL
Intervention: Homozygous for XPA (‐4A)
Number of subjects: 463

Group type: EXPERIMENTAL
Intervention: Homozygous for XPD 751Gln
Number of subjects: 463

Group type: EXPERIMENTAL
Intervention: Homozygous for XRCC3 241Met
Number of subjects: 463

Group type: EXPERIMENTAL
Intervention: Homozygous for XPA (‐4A) in adenocarcinoma cases
Number of subjects: 463

Group type: EXPERIMENTAL
Intervention: Homozygous for XRCC3 241Met in adenocarcinoma cases
Number of subjects: 463

Group type: EXPERIMENTAL
Intervention: Homozygous for two or three risk alleles (XPA (‐4A) and XPD 751Gln, XRCC3‐241Met)
Number of subjects: 463
Study: 11789775

Group type: EXPERIMENTAL
Intervention: CO2 insufflation (group I)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control (group II)
Number of subjects: 62
Study: 9182022

Group type: EXPERIMENTAL
Intervention: FAC plus dexrazoxane (administered after six courses of FAC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: FAC alone
Number of subjects: 0
Study: 8314510

Group type: EXPERIMENTAL
Intervention: Polymeric enteral nutrition
Number of subjects: 32

Group type: COMPARATOR
Intervention: Steroids (1 mg/kg/day of prednisone)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Steroids
Number of subjects: 32
Study: 3438430

Group type: EXPERIMENTAL
Intervention: Cognitive tasks (counting backward by 17's, Stroop task, spatial task)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Cognitive tasks
Number of subjects: 65
Study: 30958316

Group type: EXPERIMENTAL
Intervention: Perturbation treadmill training (PTT), n=21
Number of subjects: 43

Group type: COMPARATOR
Intervention: Conventional treadmill training (CTT), n=22
Number of subjects: 43

Group type: COMPARATOR
Intervention: Best medical treatment (BMT), n=20
Number of subjects: 43
Study: 30028478

Group type: EXPERIMENTAL
Intervention: Subcostal TAP block in addition to intravenous analgesic regimen (group II)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intravenous analgesic regimen alone (group I)
Number of subjects: 100
Study: 27480203

Group type: EXPERIMENTAL
Intervention: Nurse-initiated protocol for acetaminophen administration for patients with pain or fever
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nurse-initiated protocol for troponin testing for patients with suspected ischemic chest pain
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nurse-initiated protocol for suspected fractured hip
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nurse-initiated protocol for vaginal bleeding during pregnancy
Number of subjects: 0
Study: 25402657

Group type: EXPERIMENTAL
Intervention: Multi-frequency bioimpedance (MF-BIS)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Single-frequency bioimpedance (SF-BIA)
Number of subjects: 35
Study: 23227682

Group type: EXPERIMENTAL
Intervention: Combination of Shu‐stream and Ying‐spring acupoints (group A)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Routine acupoints (group B)
Number of subjects: 85
Study: 20353411

Group type: EXPERIMENTAL
Intervention: Gabapentin 600 mg
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 18922041

Group type: EXPERIMENTAL
Intervention: 5 mg of vitamin K1 daily
Number of subjects: 440

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 440
Study: 15838417

Group type: EXPERIMENTAL
Intervention: Telephone administration of the Stroke Impact Scale (SIS)
Number of subjects: 458

Group type: COMPARATOR
Intervention: Mail administration of the Stroke Impact Scale (SIS)
Number of subjects: 458
Study: 14503058

Group type: EXPERIMENTAL
Intervention: Dandi Tablet (DDT), 4 tablets twice a day for 3 months
Number of subjects: 73

Group type: COMPARATOR
Intervention: Nylestriol, 5 mg every month for 3 months
Number of subjects: 73
Study: 10936116

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 100 microg once daily
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 200 microg once daily
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 500 microg once daily
Number of subjects: 330

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 330
Study: 9052557

Group type: EXPERIMENTAL
Intervention: General anesthesia
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia
Number of subjects: 315
Study: 8392897

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium 4 mg four times daily
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium
Number of subjects: 69
Study: 3552842

Group type: EXPERIMENTAL
Intervention: Streptokinase (SK) treatment
Number of subjects: 561

Group type: COMPARATOR
Intervention: Control (CT) group
Number of subjects: 561
Study: 29171359

Group type: EXPERIMENTAL
Intervention: Alteplase (0.9 mg/kg)
Number of subjects: 6136
Study: 27764799

Group type: EXPERIMENTAL
Intervention: Polymeric nanoparticle containing docetaxel (PNP‐DTX) at 75 mg/m2
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Polymeric nanoparticle containing docetaxel (PNP‐DTX) at 60 mg/m2
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Polymeric nanoparticle containing docetaxel (PNP‐DTX) at 45 mg/m2
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Polymeric nanoparticle containing docetaxel (PNP‐DTX)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Docetaxel (DTX) at 75 mg/m2
Number of subjects: 18

Group type: COMPARATOR
Intervention: Docetaxel (DTX)
Number of subjects: 18
Study: 26631181

Group type: EXPERIMENTAL
Intervention: Group self-management only
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group self-management plus personalised genetic- and lifestyle-associated risk information
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 0
Study: 22999654

Group type: EXPERIMENTAL
Intervention: 0.5mg testosterone
Number of subjects: 12
Study: 20422942

Group type: EXPERIMENTAL
Intervention: New donepezil 10 mg formulation (test formulation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference product
Number of subjects: 0
Study: 18251114

Group type: EXPERIMENTAL
Intervention: Aerobic dance intervention (3 sessions per week for 6 months)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Safety education (control group, 18 sessions over 6 months)
Number of subjects: 151
Study: 16724375

Group type: EXPERIMENTAL
Intervention: Training program for general practitioners on pain management (relationships and communication, pain evaluation, prescription, negotiation of a patient contract)
Number of subjects: 842

Group type: EXPERIMENTAL
Intervention: Training program for general practitioners
Number of subjects: 842

Group type: COMPARATOR
Intervention: Control group receiving a presentation about obtaining consent in trials
Number of subjects: 842
Study: 14656913

Group type: EXPERIMENTAL
Intervention: Stenting
Number of subjects: 280

Group type: COMPARATOR
Intervention: Off-pump bypass surgery
Number of subjects: 280
Study: 11122497

Group type: EXPERIMENTAL
Intervention: Proportional hazards model with random effects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Markov chain Monte Carlo (MCMC) methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Louis' formula
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Posterior expectations and variances of individual random effects
Number of subjects: 0
Study: 8649620

Group type: EXPERIMENTAL
Intervention: Low-dose desferrioxamine (DFO) 5 mg/kg administered 5 hours prior to dialysis (group I: n = 14)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Low-dose desferrioxamine (DFO) 5 mg/kg administered in the conventional way (group II: n = 27)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Low-dose desferrioxamine (DFO) treatment
Number of subjects: 41
Study: 1462278

Group type: EXPERIMENTAL
Intervention: Mydocalm muscle relaxant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anti-inflammatory complex therapy with Mydocalm
Number of subjects: 0

Group type: COMPARATOR
Intervention: Anti-inflammatory complex therapy (control)
Number of subjects: 0
Study: 6723838

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine in combination with inhaled terbutaline
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo/terbutaline
Number of subjects: 22
Study: 31373405

Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy (CRT)
Number of subjects: 275

Group type: COMPARATOR
Intervention: Control condition (treatment as usual)
Number of subjects: 275
Study: 27371292

Group type: EXPERIMENTAL
Intervention: Immediate weight bearing
Number of subjects: 50

Group type: COMPARATOR
Intervention: Delayed weight bearing (2 months)
Number of subjects: 50
Study: 26124384

Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 158

Group type: COMPARATOR
Intervention: Control (no celecoxib)
Number of subjects: 158
Study: 23849625

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate plus formoterol (FL/F) 250/12 μg b.i.d. via dry powder inhaler (DPI)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Budesonide plus formoterol (BD/F) 400/12 μg b.i.d.
Number of subjects: 196
Study: 22052266

Group type: EXPERIMENTAL
Intervention: Small gel-particle hyaluronic acid (SGP-HA)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Large gel-particle hyaluronic acid (LGP-HA)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both SGP-HA and LGP-HA
Number of subjects: 20
Study: 19271110

Group type: EXPERIMENTAL
Intervention: Electrogastrographic recording during a 30-min interdigestive and a 120-min postprandial period
Number of subjects: 11
Study: 16495194

Group type: EXPERIMENTAL
Intervention: Thymosin alpha(1) 11.6 mg subcutaneously daily for 7 days
Number of subjects: 42

Group type: COMPARATOR
Intervention: Saline 2 ml daily for 7 days (Control)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Thymosin alpha(1)
Number of subjects: 42
Study: 15736918

Group type: EXPERIMENTAL
Intervention: Dietary supplementation with omega-3 long-chain polyunsaturated fatty acids (LC-PUFA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 11386491

Group type: EXPERIMENTAL
Intervention: naltrexone 50 mg/day
Number of subjects: 121

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: naltrexone 50 mg/day with cognitive coping skills
Number of subjects: 121

Group type: COMPARATOR
Intervention: placebo with cognitive coping skills
Number of subjects: 121
Study: 9243422

Group type: EXPERIMENTAL
Intervention: Physical fitness program as an adjunct to the usual program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physical fitness program with therapy
Number of subjects: 0
Study: 8474059

Group type: EXPERIMENTAL
Intervention: Gold therapy (early treatment)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Delayed gold therapy (treatment after 6 months)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (RA patients not receiving gold, n = 34)
Number of subjects: 23
Study: 3820493

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (1500 mg/d)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 31463667

Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 78
Study: 31600221

Group type: EXPERIMENTAL
Intervention: Methylene Blue (MB) with Artesunate-Amodiaquine (AS-AQ) (15 mg/kg/day for 3 days)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Primaquine (PQ) with Artesunate-Amodiaquine (AS-AQ) (0.25 mg/kg at day 2)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Methylene Blue (MB) with Artesunate-Amodiaquine (AS-AQ)
Number of subjects: 100
Study: 28178004

Group type: EXPERIMENTAL
Intervention: Combined Jessner solution and TCA (20%-25%)
Number of subjects: 24

Group type: COMPARATOR
Intervention: TCA (20%-25%) alone
Number of subjects: 24
Study: 25920600

Group type: EXPERIMENTAL
Intervention: Combined cup and stem anteversion according to standard combined anteversion definitions
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cup placement within Lewinnek's 'safe zone'
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Eight combined anteversion definitions
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Clinical outcome measures (HHS, HOOS, EQ-5D)
Number of subjects: 60
Study: 24012086

Group type: EXPERIMENTAL
Intervention: Vitamin A and iron supplementation (group III)
Number of subjects: 445

Group type: COMPARATOR
Intervention: Vitamin A supplementation only (group I)
Number of subjects: 445

Group type: COMPARATOR
Intervention: Iron supplementation only (group II)
Number of subjects: 445

Group type: COMPARATOR
Intervention: Placebo control (group IV)
Number of subjects: 445
Study: 21865364

Group type: EXPERIMENTAL
Intervention: Atropine (15 μg/kg bolus, 4 μg/kg · h infusion)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Physostigmine (0.12 μg/kg · min)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline (0.9% NaCl)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Atropine vs. Saline in Lean Subjects
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Physostigmine vs. Saline in Lean Subjects
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline in Lean Subjects
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Atropine vs. Saline in Obese Subjects
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Physostigmine vs. Saline in Obese Subjects
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline in Obese Subjects
Number of subjects: 12
Study: 19198709

Group type: EXPERIMENTAL
Intervention: Endotracheal ventilation catheter
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine extubation
Number of subjects: 60
Study: 17109305

Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone treatment with brief physician management
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone treatment with physician management and nurse-administered drug counseling
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone treatment
Number of subjects: 16
Study: 15230457

Group type: EXPERIMENTAL
Intervention: Children with autism spectrum disorder
Number of subjects: 30

Group type: COMPARATOR
Intervention: Comparison group (children from a mainstream school)
Number of subjects: 30
Study: 11996958

Group type: COMPARATOR
Intervention: CAD(+)DM(+): Apolipoprotein A-I/B ratio (1.7+/−0.4) vs Control (2.0+/−0.6), P<0.01
Number of subjects: 251

Group type: COMPARATOR
Intervention: CAD(+)DM(-): Apolipoprotein B (96+/−24) vs Control (85+/−18), P<0.01
Number of subjects: 251

Group type: COMPARATOR
Intervention: CAD(+)DM(+), CAD(+)DM(-)
Number of subjects: 251

Group type: COMPARATOR
Intervention: PON activity
Number of subjects: 251
Study: 9578185

Group type: EXPERIMENTAL
Intervention: Imidapril 10 mg single dose
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Imidapril 10 mg steady state (28 days therapy)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 7780282

Group type: EXPERIMENTAL
Intervention: 0.8 mg nitroglycerin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 10 mg nifedipine
Number of subjects: 12
Study: 2501775

Group type: EXPERIMENTAL
Intervention: Oral erythromycin
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Topical mupirocin
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 97
Study: 917399

Group type: EXPERIMENTAL
Intervention: Food supplementation and/or psychological stimulation
Number of subjects: 456

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 456
Study: 31788775

Group type: EXPERIMENTAL
Intervention: Prone position (P)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Lateral position (L)
Number of subjects: 51
Study: 31451978

Group type: COMPARATOR
Intervention: Internet-based cognitive behavioral therapy (iCBT) with therapist support
Number of subjects: 0

Group type: COMPARATOR
Intervention: Internet-based cognitive behavioral therapy (iCBT) without therapist support
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 0
Study: 28643064

Group type: EXPERIMENTAL
Intervention: Self-expandable metallic stent (SEMS) placement combined with intraluminal 125I seed strands brachytherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-expandable metallic stent (SEMS) without brachytherapy
Number of subjects: 0
Study: 25876640

Group type: COMPARATOR
Intervention: Sufentanil group (S) - 150 mL normal saline containing 2.5 µg/kg sufentanil citrate and 6 mg tropisetron for 48 hours
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dezocine+sufentanil group (DS) - 150 mL normal saline containing 0.25 mg/kg dezocine, 1.5 µg/kg sufentanil citrate, and 6 mg tropisetron for 48 hours
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sufentanil group (S)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dezocine+sufentanil group (DS)
Number of subjects: 60
Study: 24158983

Group type: EXPERIMENTAL
Intervention: Nurse practitioner support added to physician care
Number of subjects: 788

Group type: COMPARATOR
Intervention: Physician care alone
Number of subjects: 788
Study: 21103921

Group type: EXPERIMENTAL
Intervention: Lycopene (30 mg/day)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Fish oil (3 g/day, including 1,098 mg eicosapentaenoic and 549 mg docosahexaenoic fatty acids)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 19019930

Group type: EXPERIMENTAL
Intervention: Fibrin glue (FG) (Tisseel)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sutures
Number of subjects: 40
Study: 17400317

Group type: EXPERIMENTAL
Intervention: Contemplation condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Viewing condition
Number of subjects: 0
Study: 15257186

Group type: EXPERIMENTAL
Intervention: Indapamide SR 1.5 mg
Number of subjects: 570

Group type: COMPARATOR
Intervention: Enalapril 10 mg
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: Indapamide SR
Number of subjects: 570

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 570
Study: 11606671

Group type: EXPERIMENTAL
Intervention: PVP+PVS (unilateral GPi lesion plus contralateral GPi stimulation)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Bilateral PVP (simultaneous bilateral GPi lesion)
Number of subjects: 6
Study: 9583541

Group type: EXPERIMENTAL
Intervention: End-inspiratory pause (EIP) at 0%
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: End-inspiratory pause (EIP) at 10%
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: End-inspiratory pause (EIP) at 30%
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: End-inspiratory pause (EIP) at varying durations (0%, 10%, 30%)
Number of subjects: 11
Study: 8018682

Group type: EXPERIMENTAL
Intervention: Interactive computer software intervention
Number of subjects: 368

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 368
Study: 31615937

Group type: EXPERIMENTAL
Intervention: Abemaciclib alone
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Abemaciclib plus anastrozole
Number of subjects: 100

Group type: COMPARATOR
Intervention: Anastrozole alone
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Combination therapy (Abemaciclib + Anastrozole)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: All treatments (Abemaciclib, Anastrozole, Combination)
Number of subjects: 100
Study: 29210828

Group type: EXPERIMENTAL
Intervention: MC lenses (MiSight or Proclear Multifocal-Distance +2.00D)
Number of subjects: 43

Group type: COMPARATOR
Intervention: SV lenses (1-DAY ACUVUE MOIST)
Number of subjects: 43
Study: 27113948

Group type: EXPERIMENTAL
Intervention: Oral TXA (1.95g orally 2 hours preoperatively)
Number of subjects: 71

Group type: COMPARATOR
Intervention: IV TXA (1g IV bolus before wound closure)
Number of subjects: 71